Your browser doesn't support javascript.
loading
The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis.
Guo, Xiaonan; Zhou, Zhibo; Lyu, Xiaorui; Xu, Hanyuan; Zhu, Huijuan; Pan, Hui; Wang, Linjie; Yang, Hongbo; Gong, Fengying.
Affiliation
  • Guo X; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhou Z; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Lyu X; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xu H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhu H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Pan H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang L; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yang H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Gong F; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Horm Metab Res ; 54(7): 458-471, 2022 07.
Article in En | MEDLINE | ID: mdl-35512849
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Glucagon-Like Peptides / Liraglutide / Glucagon-Like Peptide-1 Receptor / Exenatide / Hypoglycemic Agents / Obesity Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Horm Metab Res Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Glucagon-Like Peptides / Liraglutide / Glucagon-Like Peptide-1 Receptor / Exenatide / Hypoglycemic Agents / Obesity Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Horm Metab Res Year: 2022 Type: Article Affiliation country: China